Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report Intel FAQ API Sign In →
44 /100
MEDIUM RISK
Score updated Jul 28, 2026

TRAX — First Tracks Biotherapeutics, Inc. Dilution Risk Tracker

Track TRAX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TRAX — Get alerts when the score changes →

As of July 28, 2026, First Tracks Biotherapeutics, Inc. (TRAX) has a DilutionWatch DilutionScore of 44/100, rated MEDIUM dilution risk. First Tracks Biotherapeutics, Inc. has a market capitalization of $556.88M, 34.89M shares outstanding.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄Convertible Debt

Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for TRAX.
🔔 Track TRAX — Get forecast alerts →

Market Data

Market Cap$556.88M
Shares Outstanding34.89M
Float31.08M
Cash$248.47M
DebtN/A
Short InterestN/A

Institutional Holdings

42.7% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track TRAX for full holder detail →

Short Interest

Short Interest4.77M
Days to Cover4.2
% of Float15.3%
FINRA data as of Jul 15, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news

What This Means for TRAX Shareholders

First Tracks Biotherapeutics, Inc. (TRAX) has a DilutionScore of 44/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 28, 2026.

DilutionWatch's EDGAR monitoring for TRAX shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for TRAX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch shows real-time score changes for TRAX alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Understanding TRAX's Dilution Risk Factors

Primary Risk Drivers

The two highest-risk factors for First Tracks Biotherapeutics are Offering Ability and Cash Runway, both scoring at the midpoint of the scale. Offering Ability indicates a moderate likelihood that the company could raise capital through new equity offerings, which dilutes existing shareholders. Cash Runway reflects how long the company can operate without additional funding, with a score suggesting potential financial strain. Together, these factors create a risk environment where the company may need to issue new shares to fund operations or programs, thereby increasing share count and reducing ownership percentage for current investors.

Factors Currently Not a Concern

Float Risk remains low, indicating that the company’s publicly traded shares are not heavily concentrated among a few large holders. A significant change would occur if a major shareholder decided to sell or if the company issued new stock to a small group of investors, increasing concentration risk. Warrant Exposure and Convertible Note Risk are also moderate but manageable. However, any increase in outstanding warrants or convertible notes could trigger dilution if these instruments convert into equity at below-market prices, especially if the company's stock price is low.

SEC Filings to Watch

Investors should monitor S-3 registration statements, which signal potential large-scale equity offerings. 424B5 filings often accompany new stock issuances and can indicate upcoming dilutive events. An 8-K Item 1.01 filing would alert investors to material agreements or changes in capital structure. Additionally, 10-Q reports provide quarterly updates on cash levels and financing activities that could affect future dilution risk.

How Dilution Happens

Dilution occurs when the company issues new shares to raise funds. If Offering Ability is high, the company may file for a new equity offering, increasing total shares outstanding. This directly reduces the percentage ownership of existing shareholders. Cash Runway concerns suggest that such offerings may be needed soon, and if they occur during a period of low stock price, more shares must be issued to raise the same dollar amount, further diluting current holdings.

What Would Make This Worse

A worsening risk profile would begin with an increase in Offering Ability or Cash Runway scores due to a drop in cash reserves or a decision to pursue new financing. If Convertible Notes or Warrant Exposure escalate, especially if the company enters into agreements that allow early conversion at low prices, existing shareholders face greater dilution. A combination of these factors could quickly shift the risk level from moderate to high, significantly impacting shareholder value.

Key Insight

Low scores indicate safer conditions; thus, a rise in any factor score signals increased risk for investors.

How to Monitor TRAX for Dilution Risk

What This Risk Level Means

For a small-cap operating company like First Tracks Biotherapeutics (TRAX), a medium dilution risk profile indicates that while the company is not currently in immediate danger of severe dilution, it operates in an environment where dilutive actions are possible and actively monitored. Small-cap companies often rely on equity financing to fund operations, research, or growth initiatives, making them more susceptible to dilution events such as equity offerings, warrant exercises, or convertible note conversions. A medium risk level suggests that the company's capital structure is under scrutiny but not yet in a critical state — however, vigilance is essential.

What Typically Happens Next

Companies at this profile often proceed with financing activities such as shelf registrations or ATM programs to raise capital. These mechanisms allow for flexible fundraising and can lead to dilution if executed frequently or in large volumes. Additionally, warrant exercises or convertible note conversions may occur as part of the company’s capital strategy. The timing of these events is often tied to operational milestones or market conditions. Monitoring such companies requires attention to SEC filings and regulatory updates, particularly around offerings and financing plans.

Monitoring Playbook

To effectively track TRAX using DilutionWatch, set up alerts for any changes in DilutionScore or elevated factors like Offering Ability, Cash Runway, Warrant Exposure, or Convertible Note Risk. Check the company’s profile weekly, especially around earnings announcements or after SEC filings. When thresholds are hit — such as a score rising above 50/100 — investigate the underlying cause and monitor for upcoming events like shelf filings or warrant expirations. Use Shelf & ATM Monitor to track any new offerings or financing plans.

Early Warning Signals

Three key warning signs include: 1) A sudden spike in Offering Ability score, indicating a possible upcoming equity offering; 2) An increase in Warrant Exposure or Convertible Note Risk, suggesting that warrants or notes may be exercised soon; and 3) A rise in Cash Runway score, signaling the company may be running low on cash and could issue more shares to fund operations.

What a Positive Resolution Looks Like

A positive shift in TRAX’s dilution risk profile would occur if the company raises capital through a non-dilutive mechanism such as debt financing or achieves sufficient cash reserves to reduce reliance on equity. Warrant expirations without exercise, or a reduction in convertible note balances, would also signal improvement. Any major capital raise that does not involve dilutive securities would help lower overall risk.

Watch For

Unusual spikes in Offering Ability or Convertible Note Risk scores, particularly after earnings or SEC filings, as these may indicate upcoming dilutive actions.

Full SEC filing analysis available with free account  →
Track TRAX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TRAX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TRAX
TRAX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.